![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, July 23, 2021 2:34:38 PM
It's good thing there has been no mentioning of vaccine treatment for obvious reason, and while everyone involved look serious as the deadly GBM is the subject, FDA Pazdur is smiling all the time as if he were on drug and feels high.
Title and video:
Conquer and Cure GBM: A #GBMDay Panel Discussion - National Brain Tumor Society
826 views
Streamed live on Jul 21, 2021
Some excerpts from two participants:
Dr. Ned Sharpless
Director of the National Cancer Institute
"Doesn't look like progress at all until progress arrives, ......
my father died of metastatic melanoma in 2010. The first immunotherapy drug for metastatic melanin was approved in 2011. I can promise you in 2010 things looked pretty bleak for metastatic melanoma and that we has 30 years progress and lots of new therapies and lots of ideas but it didn't really pay off until about 12 months after my dad died so you know and now we cure cure big c make the cancer go away never come back most patients with metastatic melanoma now just a mere less than 10 years later
so when the progress happens it can happen pretty quickly it doesn't look much is happening from the outside until we get there pretty quickly ......
Dr. Richard Pazdur
Director of the FDA’s Oncology Center of Excellence
"So I think the drug regulation will follow after we have effective therapies and the regulatory hurdles to getting a drug approved will be minimal really if these drugs are truly effective..."
I don't know you, but I have been buying recently all the way down from $1.6s.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM